Business Context and Reporting Period
This Form 8-K, dated August 26, 2024, reports that PowerUp Acquisition Corp. (a Cayman Islands exempted company) has entered into a definitive Business Combination Agreement with Aspire Biopharma, Inc. (a Puerto Rico corporation). The transaction involves a merger where Aspire will become a wholly-owned subsidiary of PowerUp. PowerUp is an emerging growth company listed on The Nasdaq Stock Market LLC.
Key Financial Metrics and Transaction Terms
The filing details the consideration for the business combination rather than historical financial performance metrics such as revenue or cash flow, which are not provided in this document.
- Aggregate Consideration: Aspire stockholders are entitled to receive New Aspire Common Stock with an aggregate value equal to $316.8 million.
- Adjustments: The final value is subject to reductions for (a) the amount by which Aspire's cash at closing is less than the Minimum Cash Condition (if waived) and (b) Aspire's indebtedness at closing.
- Minimum Cash Condition: Aspire must have no less than $0.00 of available cash after paying transaction expenses and liabilities.
- Termination Fees: The agreement does not provide for any termination fees.
Material Changes and Transaction Structure
The primary material change is the execution of the merger agreement. Key structural elements include:
- Domestication: Prior to closing, PowerUp will migrate from the Cayman Islands to become a Delaware corporation.
- Board Composition: The post-closing board will consist of seven directors: two designated by PowerUp (both independent) and five designated by Aspire (at least two independent).
- Management Continuity: The CEO and CFO of Aspire immediately prior to closing will serve as the CEO and CFO of the combined company immediately after closing.
- Trust Account: Aspire and its affiliates have waived any rights to PowerUp's trust account funds, except in connection with the closing.
Guidance, Outlook, Risks, and Conditions
The filing contains extensive forward-looking statements regarding the anticipated benefits and timing of the combination, which are subject to significant risks.
Conditions to Closing
- Shareholder approval from both PowerUp and Aspire.
- SEC effectiveness of the Registration Statement (Form S-4).
- Nasdaq listing approval for the new shares.
- Absence of a Material Adverse Effect on either party.
- Receipt of required governmental and third-party consents.
Key Risks and Contingencies
- Completion Risk: The transaction may not be completed by the "Outside Date" of August 17, 2025, or at all.
- Redemptions: The level of redemptions by PowerUp public shareholders could exceed anticipated levels.
- Capital Needs: Aspire may need to raise additional capital to execute its business plan, which may not be available on acceptable terms.
- Operational Risks: Risks include supply chain disruptions, failure to commercialize products, intellectual property challenges, and regulatory lawsuits.
Investor Verification Checklist
- Verify the final valuation of Aspire by monitoring the actual cash balance and indebtedness at the time of closing, as these will adjust the $316.8 million consideration.
- Review the upcoming Form S-4 registration statement for detailed risk factors and pro forma financial information.
- Monitor the status of shareholder votes required from both PowerUp and Aspire stockholders.
- Confirm the satisfaction of the Nasdaq listing requirements for the combined entity.
- Assess the potential impact of shareholder redemptions on the combined company's liquidity post-closing.